GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$173.68
+3.71%Forward multiples
Based on analyst estimates
- P/E forward
- 20.06x
- P/E 2026E
- —
- P/E 2027E
- 17.16x
- P/E 2028E
- 16.08x
- P/S forward
- 6.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.52x
- Price / sales
- 6.95x
- Price / cash flow
- 14.88x
Enterprise value
- Enterprise value
- $235.1B
- EV / sales
- 7.59x
- EV / EBITDA
- 285.70x
- EV / EBIT
- -173.15x
- Market cap
- $215.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026